Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review
{{output}}
Purpose of review: Long-acting injectable (LAI) antiretroviral therapy (ART) for treatment of HIV-1 are approved both as a complete treatment regimen (cabotegravir/rilpivirine) and as an additional treatment option (lenacapavir) ... ...
